{"id":"https://genegraph.clinicalgenome.org/r/ff167dc6-4f59-4891-bd30-4302ae97ca40v1.0","type":"EvidenceStrengthAssertion","dc:description":"TRPV4 was first reported in relation to autosomal dominant TRPV4-related skeletal dysplasia in 2008 (Rock et al., PMID: 18587396). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms or inheritance pattern. Therefore, the following disease entities have been lumped into one disease entity: brachyolmia type 3 (OMIM: 113500), Spondylometaphyseal dysplasia, Kozlowski type (SMD-K) (OMIM: 184252), spondyloepimetaphyseal dysplasia, Maroteaux type SEMD-M (OMIM: 184095), and metatropic dysplasia (OMIM: 156530). The split curation for autosomal dominant neuromuscular disease has been curated separately by the Charcot-Marie-Tooth GCEP. Eleven variants (all missense and one frameshift) that have been reported in 11 probands in 4 publications (PMIDs: 18587396, 19232556, 20503319, 21964829) are included in this curation with cases included for all four lumped disease entities. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is suggested to be gain-of-function or aberrant signaling. This gene-disease relationship is also supported by experimental evidence including biochemical function, expression, functional alterations, and multiple mouse models (PMIDs: 18762026, 21964574, 24577120, 24644033, 26249260, 31463371). In summary, there is definitive evidence supporting the relationship between TRPV4 and autosomal dominant TRPV4-related skeletal dysplasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date October 23, 2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ff167dc6-4f59-4891-bd30-4302ae97ca40","GCISnapshot":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-10-20T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-10-23T19:06:11.199Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ea39041-4cd7-4bfe-8088-a4b11d15a137","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ea39041-4cd7-4bfe-8088-a4b11d15a137_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21964829","allele":{"id":"https://genegraph.clinicalgenome.org/r/bdf0483d-d6f8-4314-895b-0e68c7dcc8ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.232G>T (p.Gly78Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129247"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/179d1dce-99d7-4aa0-83b0-721f2824b712","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/179d1dce-99d7-4aa0-83b0-721f2824b712_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant increases constitutive current.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/179d1dce-99d7-4aa0-83b0-721f2824b712_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19232556","allele":{"id":"https://genegraph.clinicalgenome.org/r/00c0f9d3-59e4-4fd3-8b9f-6fdf8e77be62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.998A>G (p.Asp333Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117170"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2bd0011a-1250-41d2-9399-369e9d8845bc","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bd0011a-1250-41d2-9399-369e9d8845bc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increase in the activity of constitutive open channels, increased intracellular calcium (Camacho et al. 2010, PMID: 20425821).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2bd0011a-1250-41d2-9399-369e9d8845bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19232556","allele":{"id":"https://genegraph.clinicalgenome.org/r/176df595-0139-4790-a437-fb1b61e7740f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.2396C>T (p.Pro799Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117176"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cadbb4bc-b7b5-43b8-aa23-432df0fab0a2","type":"EvidenceLine","dc:description":"Although the cDNA change predicts a frameshift effect, the deletion extends into the last 50 bp of exon 15/16, so it is expected to escape NMD. Upgraded for radiographs showing phenotypic specificity.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cadbb4bc-b7b5-43b8-aa23-432df0fab0a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20503319","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fdb21de-b9e3-4623-b66b-b2634a5f7707","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.2396_2412del (p.Pro799LeufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347737"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9e9bdd4c-a424-4d30-a0dd-270231400674","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e9bdd4c-a424-4d30-a0dd-270231400674_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increased channel activity compared to WT (Loukin et al. 2011, PMID: 21573172).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9e9bdd4c-a424-4d30-a0dd-270231400674_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20503319","allele":{"id":"https://genegraph.clinicalgenome.org/r/73f079e5-1047-4da5-8e03-29cb95689500","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.2389G>A (p.Glu797Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117195"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/496e82ce-0553-40c1-8bca-32b4e00827ed","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/496e82ce-0553-40c1-8bca-32b4e00827ed_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increased constitutive currents in transfected HEK cells showing GOF mechanism (Loukin et al. 2010, PMID: 20605796).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/496e82ce-0553-40c1-8bca-32b4e00827ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18587396","allele":{"id":"https://genegraph.clinicalgenome.org/r/ed9d4d0b-7a7a-4558-8988-d7bd033091f0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.1847G>A (p.Arg616Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117164"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b170db78-7b86-4817-92da-10d3b5bda6df","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b170db78-7b86-4817-92da-10d3b5bda6df_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This paper includes functional evidence demonstrating that this variant increases constitutive current.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b170db78-7b86-4817-92da-10d3b5bda6df_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19232556","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b50c0b2-642c-48c7-b3a0-5d423af43030","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.1781G>A (p.Arg594His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117168"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/94e8b9c2-b9dd-4812-a586-75bfa8f187ea","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94e8b9c2-b9dd-4812-a586-75bfa8f187ea_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increased ATP binding (Inada et al. 2012 PMID: 22702953).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/94e8b9c2-b9dd-4812-a586-75bfa8f187ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20503319","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec275765-ede3-43cc-a8ce-d2b09649e9d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.547G>A (p.Glu183Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117197"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/94323d77-4bb2-4d35-9127-84628e22dd69","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94323d77-4bb2-4d35-9127-84628e22dd69_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increase in the activity of constitutive open channels, increased intracellular calcium (Camacho et al. 2010, PMID: 20425821).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/94323d77-4bb2-4d35-9127-84628e22dd69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19232556","allele":{"id":"https://genegraph.clinicalgenome.org/r/71d9fdc6-a0f2-4864-bd7c-e3f86ae1ba8c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.991A>T (p.Ile331Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117174"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4a091d2-e4eb-43c4-ab52-1d6f3ad41efa_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18587396","rdfs:label":"Family R99-102","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/e4a091d2-e4eb-43c4-ab52-1d6f3ad41efa","type":"Family","rdfs:label":"Family R99-102","member":{"id":"https://genegraph.clinicalgenome.org/r/a14d4777-58dd-41c4-9a4e-a064a5510275","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18587396","rdfs:label":"R99-102 Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/ed9d4d0b-7a7a-4558-8988-d7bd033091f0"},"detectionMethod":"Microsatellite analysis and recombination mapping with sequencing of only TRPV4 in the linkage region.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Brachyolmia: Short-trunk short stature, mildly short limbs, mild brachydactyly, and no extraskeletal findings. Radiographs: showed scoliosis with platyspondyly and overfaced pedicles, irregular proximal femoral metaphyses, and delayed epiphyseal and carpal ossification.","phenotypes":["obo:HP_0000926","obo:HP_0003025","obo:HP_0001216","obo:HP_0002663","obo:HP_0001156","obo:HP_0002650","obo:HP_0003521"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/496e82ce-0553-40c1-8bca-32b4e00827ed_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Brachyolmia: Short-trunk short stature, mildly short limbs, mild brachydactyly, and no extraskeletal findings. Radiographs: showed scoliosis with platyspondyly and overfaced pedicles, irregular proximal femoral metaphyses, and delayed epiphyseal and carpal ossification.","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0002650","obo:HP_0003025","obo:HP_0001156","obo:HP_0001216","obo:HP_0002663","obo:HP_0000926","obo:HP_0003521"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a14d4777-58dd-41c4-9a4e-a064a5510275"},"publishedLodScore":3.04,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/0e267199-9e73-452a-977c-66f333f60296_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18587396","rdfs:label":"Family R99-457","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/0e267199-9e73-452a-977c-66f333f60296","type":"Family","rdfs:label":"Family R99-457","member":{"id":"https://genegraph.clinicalgenome.org/r/553cd5ab-6e22-4ef6-8b8c-0aba53e570f2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18587396","rdfs:label":"R99-457 Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e4191a7-8e26-4f65-9e64-6328cb7cdf1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.1858G>A (p.Val620Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117166"}},"detectionMethod":"Microsatellite analysis and recombination mapping with sequencing of TRPV4 only.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"\"Similar autosomal dominant brachyolmia phenotype\" as Family R99-102","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a3ce6885-a6af-42df-bae8-a7fd5e5d4d28_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18587396","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e4191a7-8e26-4f65-9e64-6328cb7cdf1b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"\"Similar autosomal dominant brachyolmia phenotype\" as Family R99-102","phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/553cd5ab-6e22-4ef6-8b8c-0aba53e570f2"},"publishedLodScore":1.2,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a3ce6885-a6af-42df-bae8-a7fd5e5d4d28","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3ce6885-a6af-42df-bae8-a7fd5e5d4d28_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increased constitutive current in transfected HEK cells showing GOF mechanism.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a3ce6885-a6af-42df-bae8-a7fd5e5d4d28_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1dd29d11-e5e4-4107-88ea-60d592a8d369","type":"EvidenceLine","dc:description":"Radiographs show phenotypic specificity.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dd29d11-e5e4-4107-88ea-60d592a8d369_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19232556","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4798900-6211-4e9e-9abb-8464e57e5e89","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021625.5(TRPV4):c.2146G>T (p.Ala716Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117172"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4cc464f-cd06-4851-84a7-9a6b0e0ab301","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53a683ed-54d4-428b-a83f-70f78afb1fc2","type":"Finding","dc:description":"Mutant mice displayed perinatal lethality and skeletal abnormalities. E16.5 mice were small with midface hypoplasia and short limbs and tails, and the most severely affected mice were hydropic. They had dumbbell-shaped long bones, small ribcages, abnormal autopods, and abnormal vertebral ossification. Histochemistry showed narrowed proliferative zones with widened reserve zones and less defined boundaries between zones. In many mice the phenotype was more similar to metatropic dysplasia than SMD-K, possibly because the Col2a1 promoter method resulted in higher than normal TRPV4 expression.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24644033","rdfs:label":"p.Arg594His SMD-K mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b0a90cbc-c64d-49b9-8965-2c64069497f3","type":"EvidenceLine","dc:description":"Mild phenotypes recapitulate the human dysplasia but make it difficult to determine strength of model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c46588a0-891d-48ce-947f-2c07693a2311","type":"Finding","dc:description":"Mild phenotypes observed in model recapitulate comparatively mild phenotypes of Brachyolmia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24577120","rdfs:label":"Leddy Brachyolmia Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/fda50604-09f6-48eb-8724-deb4c67f307e","type":"EvidenceLine","dc:description":"Moderate phenotypes recapitulate human Brachyolmia phenotypes but make it difficult to determine strength of model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f085f9cd-a584-4268-ba6e-6cd5d00a4ee5","type":"Finding","dc:description":"R594H mice were shown to have a range of phenotypes from moderate to severe, recapitulating range in human phenotypes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24644033","rdfs:label":"Weinstein Brachyolmia Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d25e876-8a16-4050-90d1-4a5e5c40f84e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6b2dda5-e296-4809-bc8e-17b514ee6a12","type":"FunctionalAlteration","dc:description":"Dental pulp stem cells (mesenchymal stem cells that differentiate into bone lineage cells) from a patient with non-lethal metatropic dysplasia carrying c.1855C>T (p.Leu619Phe) showed increased intracellular calcium concentration, accelerated early chondrocyte differentiation, and SOX9 upregulation after stimulation with TRPV4 agonist.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31463371","rdfs:label":"In vitro study of patient-derived dental pulp stem cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a895345e-c288-4358-8371-5250965995a5","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fd72774-119a-423f-9f17-84c5e627e8c6","type":"FunctionalAlteration","dc:description":"Compared to controls, primary chondrocytes from a patient with severe infantile metatropic dysplasia, carrying c.2399G>A (p.Gly800Asp), showed increased magnitudes of calcium concentration during temperature-dependent oscillations. Oscillations were longer and more frequent. Ca2+ concentration was also increased at baseline and in response to hypotonic swelling and a TRPV4 agonist. p.P799L was used as a positive control.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26249260","rdfs:label":"Functional alteration in patient chondrocytes"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/13bce420-9049-41ae-b1e8-ebcae68a3f9e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd810e44-8f9d-4407-94d6-1778fe1e2da4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18495231-64aa-491b-9bf2-ad20f7337d8b","type":"Finding","dc:description":"While LOF is demonstrated here and the TRPV4 bone disorders are caused by GOF variants, the ClinGen Skeletal Disorders GCEP agreed that this study demonstrated the biochemical function of the TRPV4 channel.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18762026","rdfs:label":"Function in mouse osteoclasts","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b909525a-655d-4014-8a2f-24fb45467114","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/457220f6-179d-4ac5-b734-70f5e58eb576","type":"Finding","dc:description":"Immunostaining showed that TRPV4 protein was expressed in mouse growth plate and articular cartilage. It localized to the proliferative and prehypertrophic zones of the growth plate.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21964574","rdfs:label":"Expression in mouse growth plate and articular cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fd59ac79-ce96-4b09-992a-2a0be28f22e4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63019269-9ffe-4675-b634-25634e9f4aaa","type":"Finding","dc:description":"Western blot showed that TRPV4 was expressed in the plasma membrane of wild-type mouse osteoclasts.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18762026","rdfs:label":"Masuyama Expression Study","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":7131,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/tpCCbupB3ow","type":"GeneValidityProposition","disease":"obo:MONDO_0018240","gene":"hgnc:18083","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_13bce420-9049-41ae-b1e8-ebcae68a3f9e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}